1. Clarke, B. E., Newton, S. E., Carroll, A. R., Francis, M. J., Appleyard, G., Syred, A. D., et al. (1987). Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein. Nature, 330, 381–384.
2. Borisova, G., Bundule, M., Grinstein, E., Dreilina, D., Dreimane, A., Kalis, J., et al. (1987). Recombinant capsid structures for exposure of protein antigenic epitopes. Molecular Genetics, 6, 169–174.
3. Peyret, H., Stephen, S., Stonehouse, N. J., & Rowlands, D. J. (2015). History and potential of hepatitis B virus core as a VLP vaccine platform. In Y. Khudyakov & P. Pumpens (Eds.), Viral nanotechnology (pp. 177–186). Boca Raton: CRC Press.
4. Pumpens, P., & Grens, E. (2001). HBV core particles as a carrier for B cell/T cell epitopes. Intervirology, 44, 98–114.
5. Pumpens, P., Ulrich, R., Sasnauskas, K., Kazaks, A., Ose, V., & Grens, E. (2008). Construction of novel vaccines on the basis of the virus-like particles: Hepatitis B virus proteins as vaccine carriers. In Y. Khudyakov (Ed.), Medicinal protein engineering (pp. 205–248). Boca Raton: CRC Press.